Lyka Labs Limited (LYKALABS.NS)

INR 156.41

(1.68%)

Total Debt Summary of Lyka Labs Limited

Lyka Labs Limited's latest annual total debt in 2023 was 586.5 Million INR , down -21.41% from previous year.
Lyka Labs Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
Lyka Labs Limited reported annual total debt of 746.29 Million INR in 2022, down -42.44% from previous year.
Lyka Labs Limited reported annual total debt of 1.29 Billion INR in 2021, down -20.27% from previous year.
Lyka Labs Limited reported quarterly total debt of 540.62 Million INR for 2023 Q2, down 0.0% from previous quarter.
Lyka Labs Limited reported quarterly total debt of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Debt Chart of Lyka Labs Limited (2023 - 2009)

Historical Annual Total Debt of Lyka Labs Limited (2023 - 2009)

Year	Total Debt	Total Debt Growth
2023	586.5 Million INR	-21.41%
2022	746.29 Million INR	-42.44%
2021	1.29 Billion INR	-20.27%
2020	1.62 Billion INR	14.2%
2019	1.42 Billion INR	49.08%
2018	955.28 Million INR	-14.56%
2017	1.11 Billion INR	-10.02%
2016	1.24 Billion INR	10.11%
2015	1.12 Billion INR	27.11%
2014	887.72 Million INR	-28.53%
2013	1.24 Billion INR	-1.43%
2012	1.26 Billion INR	-1.85%
2011	1.28 Billion INR	12.17%
2010	1.14 Billion INR	4.98%
2009	1.09 Billion INR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	- INR	-100.0%
2023 Q2	540.62 Million INR	0.0%
2023 Q1	- INR	-100.0%
2023 FY	586.5 Million INR	-21.41%
2023 Q4	586.5 Million INR	0.0%
2023 Q3	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q2	1.29 Billion INR	0.0%
2022 Q1	- INR	-100.0%
2022 FY	746.29 Million INR	-42.44%
2022 Q4	746.29 Million INR	0.0%
2021 FY	1.29 Billion INR	-20.27%
2021 Q2	1.24 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2021 Q1	- INR	-100.0%
2021 Q4	1.29 Billion INR	0.0%
2020 Q4	1.62 Billion INR	0.0%
2020 Q3	- INR	-100.0%
2020 Q2	1.48 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 FY	1.62 Billion INR	14.2%
2019 Q4	1.42 Billion INR	0.0%
2019 FY	1.42 Billion INR	49.08%
2019 Q3	- INR	-100.0%
2019 Q2	928.79 Million INR	0.0%
2019 Q1	- INR	-100.0%
2018 Q1	- INR	0.0%
2018 FY	955.28 Million INR	-14.56%
2018 Q4	955.28 Million INR	0.0%
2017 FY	1.11 Billion INR	-10.02%
2016 Q4	852.39 Million INR	0.0%
2016 Q1	- INR	-100.0%
2016 Q2	902.18 Million INR	0.0%
2016 FY	1.24 Billion INR	10.11%
2016 Q3	- INR	-100.0%
2015 FY	1.12 Billion INR	27.11%
2015 Q2	725.08 Million INR	0.0%
2015 Q4	1.22 Billion INR	68.38%
2015 Q1	- INR	-100.0%
2015 Q3	725.08 Million INR	0.0%
2014 Q4	1.38 Billion INR	0.0%
2014 Q1	1.17 Billion INR	0.0%
2014 FY	887.72 Million INR	-28.53%
2013 Q3	- INR	-100.0%
2013 Q1	1.49 Billion INR	18.55%
2013 FY	1.24 Billion INR	-1.43%
2013 Q2	1.27 Billion INR	-14.73%
2012 Q4	1.26 Billion INR	0.0%
2012 FY	1.26 Billion INR	-1.85%
2012 Q3	- INR	0.0%
2012 Q2	- INR	0.0%
2011 FY	1.28 Billion INR	12.17%
2010 FY	1.14 Billion INR	4.98%
2009 FY	1.09 Billion INR	0.0%

Peer Total Debt Comparison of Lyka Labs Limited

Name	Total Debt	Total Debt Difference
Biocon Limited	162.76 Billion INR	99.64%
Blue Jet Healthcare Limited	16.12 Million INR	-3536.088%
Concord Biotech Limited	97.37 Million INR	-502.305%
Dishman Carbogen Amcis Limited	23.12 Billion INR	97.464%
Jubilant Ingrevia Limited	7.4 Billion INR	92.077%
Panacea Biotec Limited	209.9 Million INR	-179.419%
Piramal Pharma Limited	47.1 Billion INR	98.755%
SMS Lifesciences India Limited	1 Billion INR	41.771%
Supriya Lifescience Limited	54.88 Million INR	-968.697%
Syngene International Limited	5.55 Billion INR	89.436%
TAKE Solutions Limited	370.85 Million INR	-58.15%
Zota Health Care Limited	952.84 Million INR	38.447%